BeStock  
Stocks › Biotechnology › SVRA

Savara SVRA

US equityMarket cap rank #3240Biotechnology
$4.88 +$0.23 (+4.95%)
Pre-market · Oct 8, 9:10 am ET · After hours $4.98 +1.95%
Open$4.74
Prev close$4.65
Day range$4.69 – $5.05
Volume2.42M
Market cap$1.00B
P/E (TTM)–
Dividend yield–

Earnings

Average move on report day±4.4%last 12 reports
Closed higher4 of 1233% of the time
Best reaction+4.6%
Worst reaction-9.8%

Stock move on the day after each report

-1.2%2017/Q3-0.1%2017/Q4-1.4%2018/Q1+0.7%2018/Q2+2.6%2018/Q3-5.5%2018/Q4+4.6%2019/Q1-8.4%2019/Q2-6.9%2019/Q3-9.8%2019/Q4-7.8%2020/Q1+3.9%2020/Q2
QuarterReport dateTimingImplied moveActual moveVersus implied
2020/Q26 Aug 2020None±31.9%+3.92%Within range
2020/Q17 May 2020None±25.5%-7.84%Within range
2019/Q412 Mar 2020None–-9.80%–
2019/Q37 Nov 2019None–-6.91%–
2019/Q28 Aug 2019None–-8.37%–
2019/Q19 May 2019None–+4.57%–
2018/Q413 Mar 2019After Market–-5.47%–
2018/Q37 Nov 2018None–+2.61%–
2018/Q29 Aug 2018None–+0.70%–
2018/Q19 May 2018Pre Market–-1.41%–
2017/Q414 Mar 2018Pre Market–-0.10%–
2017/Q38 Nov 2017None–-1.16%–

"Implied move" is the size of move the options market was pricing ahead of the report. Move is the stock’s change on the first session after the release.

Latest reported quarter: Q2, ended Jun 2026

Revenue$0.00
Operating profit-$40.97M-30.3% YoY
Net profit-$40.23M-32.3% YoY
Diluted EPS-$0.16-14.3% YoY
Free cash flow-$29.97M-14.1% YoY
Operating cash flow-$29.75M

Revenue, last 8 quarters

$0.0Sep '24$0.0Dec '24$0.0Mar '25$0.0Jun '25$0.0Sep '25$0.0Dec '25$0.0Mar '26$0.0Jun '26

Net profit, last 8 quarters

$-24.2MSep '24$-29.0MDec '24$-26.6MMar '25$-30.4MJun '25$-29.6MSep '25$-32.2MDec '25$-37.3MMar '26$-40.2MJun '26

Profitability & balance sheet

Return on equity-105.5%
Return on assets-78.3%
Return on invested capital-88.2%
Current ratio10.13
Liabilities / assets25.2%
Cash & investments$173.03M
Total debt$30.11M
Net cash (debt)$142.93M

Discussion

No comments yet — be the first to weigh in on SVRA.

Leave a comment

Scroll to Top